<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0038">
 <label>38</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Li</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Luo</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guo</surname>
    <given-names>Q</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Discovery of N1-(4-((7-cyclopentyl-6-(dimethylcarbamoyl)-7 H-pyrrolo[2,3- d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a novel inhibitor targeting cyclin-dependent kinase 4/9 (CDK4/9) and histone deacetlyase1 (HDAC1) against malignant cancer</article-title>. 
  <source>J Med Chem</source>
  <year>2018</year>;
  <volume>61</volume>:
  <fpage>3166</fpage>–
  <lpage>92</lpage>.
  <pub-id pub-id-type="pmid">29518312</pub-id>
 </mixed-citation>
</ref>
